Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetSerine/threonine-protein kinase PLK1
LigandBDBM50232581
Substrate/Competitorn/a
Meas. Tech.ChEBML_1648127
IC50 3.9±n/a nM
Citation Kiryanov, ANatala, SJones, BMcBride, CFeher, VLam, BLiu, YHonda, KUchiyama, NKawamoto, THikichi, YZhang, LHosfield, DSkene, RZou, HStafford, JCao, XIchikawa, T Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors. Bioorg Med Chem Lett27:1311-1315 (2017) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
Serine/threonine-protein kinase PLK1
Name:Serine/threonine-protein kinase PLK1
Synonyms:PLK | PLK-1 | PLK1 | PLK1_HUMAN | Polo-like kinase 1 (PlK1) | Polo-like kinase 1 (Plk-1) | STPK13 | Serine/threonine-protein kinase (PLK1) | Serine/threonine-protein kinase 13 | polo-like kinase
Type:Serine/threonine-protein kinase
Mol. Mass.:68277.16
Organism:Homo sapiens (Human)
Description:P53350
Residue:603
Sequence:
MSAAVTAGKLARAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLG
KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF
EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG
NLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI
MYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL
NDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNKGLENPLPERPREKEE
PVVRETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDK
YGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLK
YFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTK
LILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRL
KAS
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50232581
n/a
NameBDBM50232581
Synonyms:CHEMBL4096151
TypeSmall organic molecule
Emp. Form.C36H47FN10O2
Mol. Mass.670.8226
SMILESCC[C@H]1N(C(C)C)c2nc(Nc3cc(F)c(cc3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)ncc2-n2cnc(C#N)c12 |r,wU:2.1,26.30,wD:23.23,(65.63,.49,;65.63,2.03,;64.3,2.79,;62.97,2.04,;62.96,.5,;61.62,-.27,;64.29,-.28,;61.65,2.82,;60.32,2.04,;58.99,2.81,;57.66,2.02,;57.66,.48,;58.99,-.28,;59,-1.82,;60.34,-2.58,;57.67,-2.6,;56.33,-1.83,;56.33,-.29,;54.99,.48,;54.99,2.02,;57.67,-4.14,;59.01,-4.9,;56.34,-4.91,;56.34,-6.45,;55.01,-7.22,;55.01,-8.75,;56.34,-9.53,;57.68,-8.75,;57.68,-7.21,;56.34,-11.06,;55.01,-11.82,;55,-13.36,;56.33,-14.13,;56.32,-15.67,;54.99,-16.44,;53.45,-16.43,;54.21,-17.77,;57.67,-13.37,;57.68,-11.82,;58.98,4.34,;60.31,5.12,;61.65,4.34,;62.98,5.12,;63.31,6.61,;64.83,6.75,;65.44,5.36,;66.95,5.02,;68.45,4.69,;64.3,4.34,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: